To elucidate the cell types that express RIPK1 in MS lesions, we used single-nucleus RNA-seq from control and MS patients (Schirmer et al., 2019), which demonstrated RIPK1 is ubiquitously expressed in the CNS (Figure 1F). The gene discussed is RIPK1; the disease is myeloid sarcoma.